Role of serum amyloid a in abdominal aortic aneurysm and related cardiovascular diseases

Preetha Shridas, Avery C. Patrick, Lisa R. Tannock

Research output: Contribution to journalArticlepeer-review

13 Scopus citations


Epidemiological data positively correlate plasma serum amyloid A (SAA) levels with cardiovascular disease severity and mortality. Studies by several investigators have indicated a causal role for SAA in the development of atherosclerosis in animal models. Suppression of SAA attenuates the development of angiotensin II (AngII)-induced abdominal aortic aneurysm (AAA) formation in mice. Thus, SAA is not just a marker for cardiovascular disease (CVD) development, but it is a key player. However, to consider SAA as a therapeutic target for these diseases, the pathway leading to its involvement needs to be understood. This review provides a brief description of the pathobiological significance of this enigmatic molecule. The purpose of this review is to summarize the data relevant to its role in the development of CVD, the pitfalls in SAA research, and unanswered questions in the field.

Original languageEnglish
Article number1883
Issue number12
StatePublished - Dec 2021

Bibliographical note

Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.


  • Abdominal aortic aneurysm
  • Cardiovascular disease
  • HDL
  • Serum amyloid A

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology


Dive into the research topics of 'Role of serum amyloid a in abdominal aortic aneurysm and related cardiovascular diseases'. Together they form a unique fingerprint.

Cite this